Evaxion A (EVAX) Research & Development (2020 - 2026)

Evaxion A (EVAX) has 7 years of Research & Development data on file, last reported at -$2.3 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development fell 6.59% year-over-year to -$2.3 million; the trailing twelve-month figure through Mar 2026 stood at -$10.1 million (down 3.45% YoY), and the FY2025 full-year result was -$10.0 million, up 4.61% from the prior year.
• Research & Development for Q1 2026 stood at -$2.3 million, up from -$2.6 million in the prior quarter.
• Across five years, Research & Development topped out at $4.8 million in Q1 2022 and bottomed at -$4.1 million in Q4 2022.
• The 5-year median for Research & Development is -$2.6 million (2025), against an average of -$1.5 million.
• Peak annual rise in Research & Development reached 43.58% in 2023, while the deepest fall reached 180.18% in 2023.
• A 5-year view of Research & Development shows it stood at -$4.1 million in 2022, then jumped by 43.58% to -$2.3 million in 2023, then rose by 1.87% to -$2.3 million in 2024, then dropped by 13.48% to -$2.6 million in 2025, then increased by 10.2% to -$2.3 million in 2026.
• The last three Research & Development figures came in at -$2.3 million (Q1 2026), -$2.6 million (Q4 2025), and -$3.1 million (Q3 2025), per Business Quant data.

Peer Comparison